|
|
Other links at Articles > Allergy and Clinical Immunology |
| 2. |
FDA Safety Changes: Apidra, Ontak, Raptiva
|
|
|
The FDA has approved revisions to the safety labeling for insulin glulisine [rDNA origin] injection (Apidra), denileukin diftitox (Ontak), and efalizumab (Raptiva). Medscape Medical News
|
|
|